Health Care
Cell & Gene Therapy
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$1.6M
1 round on record
Latest round
$1.6M
Venture round · Apr 2026 · 6 mo ago
Team
1-10
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2026 | $1.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Sweet Chemistry, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Joel MazaExecutive Officer, DirectorSEC Form D
Overview
Where regenerative medicine meets uncompromising cosmetic science to create evidence-based skincare worth the hype.
People

Joel Maza
Executive Officer, Director

Kenneth Suslow
Director

Andrea Nye
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
1-10 est. staff
Financials
Total raised
$1.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $1.6M | Details |
